Exclusive

Publication

Byline

Location

Indian Shares End Lower On Tariff Concerns

India, Jan. 6 -- Indian shares ended lower on Tuesday to extend losses from the previous session as investors weighed the risk of fresh U.S. tariffs and rising geopolitical tensions against a steady f... Read More


Canadian Stocks Move Higher, Aided By A Surge In Mining Stocks

India, Jan. 6 -- Canadian stocks edged higher on Tuesday, extending yesterday's gains, as metal stocks continued to trade positively due to increasing safe-haven demand for gold amid ongoing geopoliti... Read More


TSX Up Marginally; Resources Stocks Shine

India, Jan. 6 -- Materials and energy stocks are among the top gainers in the Canadian market where the mood remains somewhat cautious on Tuesday with investors digesting the data on the nation's manu... Read More


Johnson & Johnson's Phase 2b JASMINE Study Of Nipocalimab In SLE Meets Primary Endpoint

India, Jan. 6 -- Johnson & Johnson (JNJ) on Tuesday reported positive topline results from the Phase 2b JASMINE study of nipocalimab in adults with systemic lupus erythematosus (SLE). The study met i... Read More


Genprex Reports Positive Preclinical Data For Diabetes Gene Therapy Candidate GPX-002

India, Jan. 6 -- Genprex, Inc. (GNPX) on Tuesday reported preliminary preclinical data showing its diabetes gene therapy candidate GPX-002 improved glucose control in Type 2 diabetes animal models. I... Read More


Polyrizon Announces Positive Data From PL-14 Allergy Blocker Formulation Study

India, Jan. 5 -- Polyrizon Ltd. (PLRZ), Monday announced positive results from a new in-vitro pre-clinical study, evaluating the allergen-blocking performance of its PL-14 Allergy Blocker formulation ... Read More


Genelux Reports Positive Interim Results From Olvi-Vec Lung Cancer Trials

India, Jan. 5 -- Genelux Corporation (GNLX) on Monday reported interim results from two ongoing trials evaluating Olvi-Vec in patients with progressive lung cancer: a Phase 1b/2 study in small cell lu... Read More


Zenas: Phase 3 INDIGO Trial Of Obexelimab Meets Primary Endpoint

India, Jan. 5 -- Zenas BioPharma (ZBIO) reported positive results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease. Obexelimab met the primary endpoint, demonstrating 5... Read More


Twitter And Pinterest Founders Launch New Social App Aimed At Healthier Online Living

India, Jan. 5 -- Two experienced folks from Silicon Valley who helped create some of the biggest social media platforms are now supporting a new app aimed at tackling the negative effects of today's s... Read More


Wegmans Expands Use Of Facial And Voice Recognition At New York City Stores

India, Jan. 5 -- Wegmans Food Markets has started using facial and voice recognition tech to keep an eye on customers at its two locations in New York City, as reported in the news. Signs in the stor... Read More